Skip to main content
Accueil
  • fr
  • en

Main navigation

  • Company
    • Company profile
    • Management
    • Our history
    • Great Place to Work
  • Science
    • Scientific approach
    • Innate Immunity & NK cells
    • Antibody formats
    • Publications
  • Products
    • Pipeline overview
    • Clinical trials
    • ------------------
    • Lacutamab
    • Monalizumab
    • Avdoralimab
    • IPH5201
    • IPH5301
    • IPH6101
    • IPH62
    • ------------------
    • LUMOXITI
  • Partnering
  • Investors
  • Media
    • Media hub
    • All press releases
    • Media center
  • Careers

Lacutamab, a first-in-class antibody for cutaneous t-cell lymphoma


More about our lead asset

Harnessing the power of NK cells to develop therapeutic antibodies


Discover our cutting-edge science

Collaborating with a strong network to advance our pipeline


Discover our partnering opportunities

Previous Next

About Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

See company profile

Latest news

Number of shares and voting rights of Innate Pharma as of February 1, 2021

February 24, 2021

Innate Pharma to participate in the 10th annual SVB Leerink Global Healthcare Conference

February 17, 2021

Innate Pharma advances lacutamab clinical development program

February 9, 2021
See all press releases

Footer

  • Contact
  • Location
  • Legal Info
  • Terms of use
  • Privacy Notice
  • Cookies notice

Follow us

   

Stay in touch

 Subscribe to our newsletter

 Contact us
 

Location

117, Avenue de Luminy - BP 30191
13 009 Marseille FRANCE

 +33 (0)4 30 30 30 30

 Innate Pharma, Inc.
2273 Research Boulevard, Suite 350
Rockville, MD 20850, USA

Innate Pharma